SW

Steve Worland

Former President & CEO

eFFECTOR Therapeutics

Roles

Former President & CEOateFFECTOR Therapeutics

Therapeutic Areas

eFFECTOR Therapeutics Pipeline

DrugIndicationPhase
ZotatifinKRAS-mutant NSCLC; ER+ Breast CancerPhase 1b/2
TomivosertibMetastatic Castration-Resistant Prostate Cancer (mCRPC)Phase 2